Timothy Noyes is the Chief Executive Officer of Aerovate Therapeutics, a clinical-stage biopharmaceutical company focused on rare cardiopulmonary diseases.
Timothy Noyes is the Chief Executive Officer of Aerovate Therapeutics, a clinical-stage biopharmaceutical company focused on rare cardiopulmonary diseases. He previously served as President and CEO of Newleos Therapeutics, where he led a Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library